This Antibody was verified by Relative expression to ensure that the antibody binds to the antigen stated. View Details
MA5-15926 targets NQO1 in FACS, IHC, and WB applications and shows reactivity with Human samples.
The MA5-15926 immunogen is purified recombinant fragment of human NQO1 expressed in E. Coli. .
MA5-15926 detects NQO1 which has a predicted molecular weight of approximately 31kDa.
NQO1 is a member of the NAD(P)H dehydrogenase (quinone) family and a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. NQO1's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Altered expression of the protein has been seen in many tumors and is also associated with Alzheimer's disease (AD).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Azoreductase; DHQU, DIA4, DTD, NMOR1, NMORI, QR1, DT-diaphorase; diaphorase (NADH/NADPH) (cytochrome b-5 reductase); diaphorase 4 (NADH/NADPH); diaphorase-4; dioxin-inducible 1; DT-diaphorase; DTD; Menadione reductase; NAD(P)H dehydrogenase (quinone); NAD(P)H dehydrogenase [quinone] 1; NAD(P)H dehydrogenase, quinone 1; NAD(P)H menadione oxidoreductase 1, dioxin inducible; NAD(P)H:menadione oxidoreductase 1; NAD(P)H:Quinone acceptor oxidoreductase type 1; NAD(P)H:quinone oxidoreductase 1; NAD(P)H:quinone oxireductase; NQ01; Phylloquinone reductase; QR1; Quinone reductase 1
Gene Aliases: AV001255; DHQU; DIA4; DTD; Nmo-1; Nmo1; NMOR1; NMORI; NQO1; Ox-1; Ox1; QR1